share_log

Shinva Medical InstrumentLtd (SHSE:600587) Sheds 4.5% This Week, as Yearly Returns Fall More in Line With Earnings Growth

Shinva Medical InstrumentLtd (SHSE:600587) Sheds 4.5% This Week, as Yearly Returns Fall More in Line With Earnings Growth

Shinva Medical InstrumentLtd(SHSE: 600587)本週下跌4.5%,原因是年回報率下降與收益增長更加一致
Simply Wall St ·  2023/12/05 20:23

Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, the Shinva Medical Instrument Co.,Ltd. (SHSE:600587) share price is up 87% in the last 5 years, clearly besting the market return of around 33% (ignoring dividends). However, more recent returns haven't been as impressive as that, with the stock returning just 12% in the last year , including dividends .

選股者通常在尋找表現優於大盤的股票。事實是,如果你以合適的價格收購優質的企業,你就能獲得可觀的收益。例如,Shinva 醫療器械有限公司, Ltd.(SHSE: 600587)的股價在過去5年中上漲了87%,顯然超過了約33%的市場回報率(不包括股息)。但是,最近的回報並沒有那麼令人印象深刻,該股去年的回報率僅爲12%,包括股息。

While this past week has detracted from the company's five-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment.

儘管過去一週減損了該公司的五年回報率,但讓我們來看看基礎業務的最新趨勢,看看漲幅是否一致。

Check out our latest analysis for Shinva Medical InstrumentLtd

查看我們對 Shinva Medical InstrumentLtd 的最新分析

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

儘管一些人繼續教導高效市場假說,但事實證明,市場是反應過度的動態系統,投資者並不總是理性的。研究市場情緒如何隨着時間的推移而變化的一種方法是研究公司股價與其每股收益(EPS)之間的相互作用。

Over half a decade, Shinva Medical InstrumentLtd managed to grow its earnings per share at 22% a year. This EPS growth is higher than the 13% average annual increase in the share price. So it seems the market isn't so enthusiastic about the stock these days.

在過去的五年中,Shinva Medical InstrumentLtd設法將其每股收益增長了22%。每股收益的增長高於股價每年平均增長13%。因此,如今市場似乎對這隻股票並不那麼熱情。

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

您可以在下圖中看到 EPS 隨時間推移的變化(點擊圖表查看確切值)。

earnings-per-share-growth
SHSE:600587 Earnings Per Share Growth December 6th 2023
上海證券交易所:600587 每股收益增長 2023 年 12 月 6 日

We know that Shinva Medical InstrumentLtd has improved its bottom line lately, but is it going to grow revenue? If you're interested, you could check this free report showing consensus revenue forecasts.

我們知道Shinva Medical InstrumentLtd最近提高了利潤,但它會增加收入嗎?如果你有興趣,可以查看這份顯示共識收入預測的免費報告。

What About Dividends?

分紅呢?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Shinva Medical InstrumentLtd's TSR for the last 5 years was 92%, which exceeds the share price return mentioned earlier. This is largely a result of its dividend payments!

重要的是要考慮任何給定股票的股東總回報率以及股價回報。股價回報僅反映股價的變化,而股東總回報率包括股息的價值(假設股息已被再投資)以及任何折扣融資或分拆的收益。因此,對於支付豐厚股息的公司來說,股東總回報率通常遠高於股價回報。碰巧的是,Shinva Medical InstrumentLtd在過去5年的股東總回報率爲92%,超過了前面提到的股價回報率。這在很大程度上是其股息支付的結果!

A Different Perspective

不同的視角

We're pleased to report that Shinva Medical InstrumentLtd shareholders have received a total shareholder return of 12% over one year. And that does include the dividend. However, the TSR over five years, coming in at 14% per year, is even more impressive. It's always interesting to track share price performance over the longer term. But to understand Shinva Medical InstrumentLtd better, we need to consider many other factors. Case in point: We've spotted 2 warning signs for Shinva Medical InstrumentLtd you should be aware of.

我們很高興地向大家報告,Shinva Medical InstrumentLtd的股東在一年內獲得了12%的股東總回報率。這確實包括股息。但是,五年內的股東總回報率爲每年14%,更令人印象深刻。從長遠來看,追蹤股價表現總是很有意思的。但是,爲了更好地了解Shinva Medical InstrumentLtd,我們需要考慮許多其他因素。一個很好的例子:我們已經發現了 Shinva Medical InstrumentLtd 的兩個警告信號,你應該注意。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

如果你想看看另一家公司——一家財務狀況可能優異的公司——那麼千萬不要錯過這份已經證明自己可以增加收益的公司的免費名單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論